Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2008;53:1352–7.
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80.
Shimada M, Hashimoto E, Taniai M. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–60.
Sugimoto K, Takei Y. Clinicopathological features of nonalcoholic fatty liver disease. Hepatol Res. 2011;41:911–20.
Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2011;51:212–23.
Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity. Clin Transl Med. 2015;4:4–5.
Wong KL, Tai JJ, Wong WC. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118:e16–e31.
Anbazhagan K, Duroux-Richard I, Jorgensen C, Apparailly F. Transcriptomic network support distinct roles of classical and non-classical monocytes in human. Int Rev Immunol. 2014;33:470–89.
Seidler S, Zimmermann HW, Weiskirchen R, Trautwein C, Tacke F. Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes. BMC Gastroenterol. 2012;12:38.
Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH. Super SAGE evidence for CD14+CD16+monocytes as a third monocyte subset. Blood. 2011;118:50–61.
Fingerle G, Pforte A, Passlick B, Blumenstein M. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993;82:3170–6.
Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2004;43:547–54.
Katayama K, Matsubara T, Fujiwara M. CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 2000;121:566–70.
Okamoto H, Mizuno K, Horio T. Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. J Dermatol. 2003;30:503–9.
Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, Rupprecht HJ. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost. 2004;92:419–24.
Zimmermann HW, Seidler S, Nattermann J. Functional contribution of elevated circulating and hepatic nonclassical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE. 2010;5:e11049.
Kim HL, Chung GE, Park IY, Choi JM, Hwang SM, Lee JH, Kim D. Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease. Tohoku J Exp Med. 2011;223:227–33.
Wang Y. A nonclassical monocyte phenotype in peripheral blood is associated with nonalcoholic fatty liver disease: a report from an EMIL subcohort. Horm Metab Res. 2016;48:54–61.
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112.
Nati M. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29–39.
Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity. Clin Transl Med. 2015;4:5.
Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci Rep. 2015;5:13886.